# Scandinavian Starch for Severe Sepsis/Septic Shock Trial

> **NCT00962156** · PHASE3 · COMPLETED · sponsor: **Anders Perner** · enrollment: 804 (actual)

## Conditions studied

- Severe Sepsis
- Septic Shock

## Interventions

- **DRUG:** 6% Hydroxyethyl starch 130/0.4
- **DRUG:** Ringers acetate

## Key facts

- **NCT ID:** NCT00962156
- **Lead sponsor:** Anders Perner
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 804 (ACTUAL)
- **Last updated:** 2012-07-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00962156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00962156, "Scandinavian Starch for Severe Sepsis/Septic Shock Trial". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00962156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*